HILSX | OANIX | HILSX / OANIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 8 years | - |
Gain YTD | 10.148 | 1.270 | 799% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.41B | 18.4B | 29% |
Annual Yield % from dividends | 2.32 | 2.11 | 110% |
Returns for 1 year | 20.01 | 13.34 | 150% |
Returns for 3 years | 23.86 | -4.21 | -566% |
Returns for 5 years | 49.66 | 21.64 | 229% |
Returns for 10 years | 64.08 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETIHX | 37.68 | 0.84 | +2.28% |
Eventide Healthcare & Life Sciences I | |||
HAGCX | 55.59 | 0.29 | +0.52% |
Carillon Eagle Mid Cap Growth C | |||
MASCX | 12.69 | 0.06 | +0.48% |
BlackRock Sustainable Advantage GlEqInvA | |||
RICIX | 10.72 | 0.01 | +0.09% |
T. Rowe Price Intl Disciplined Eq I | |||
TNVRX | 17.91 | N/A | N/A |
1290 GAMCO Small/Mid Cap Value R |